Newron Pharmaceuticals SpA logo

Newron Pharmaceuticals SpA

CHF 1.21 (-5.1%) Sep 29
P/E:
At Loss
P/B:
7.04
Market Cap:
CHF 22.75M ($ 23.29M)
Enterprise V:
CHF 30.83M ($ 31.56M)
Volume:
19.38K
Avg Vol (2M):
5.67K
Also Trade In:
Volume:
19.38K
Market Cap CHF:
22.75M
Market Cap $:
23.29M
PE Ratio:
At Loss
Avg Vol (2-Month):
5.67K
Enterprise Value CHF:
30.83M
Enterprise Value $:
31.56M
PB Ratio:
7.04
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.8
Equity-to-Asset 0.06
Debt-to-Equity 13.87
Debt-to-EBITDA -3.55
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.09
Distress
Grey
Safe
Beneish M-Score -3.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.6
9-Day RSI 30.41
14-Day RSI 33.96
6-1 Month Momentum % 8.85
12-1 Month Momentum % -28.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.79
Quick Ratio 10.79
Cash Ratio 9.47
Days Sales Outstanding 102.78

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials

XSWX:NWRN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 6.138
EPS (TTM) (CHF) -0.901
Beta 0.42
Volatility % 23.22
14-Day RSI 33.96
14-Day ATR (CHF) 0.080501
20-Day SMA (CHF) 1.36225
12-1 Month Momentum % -28.17
52-Week Range (CHF) 1.2 - 2.1
Shares Outstanding (Mil) 17.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Newron Pharmaceuticals SpA Filings

Document Form Filing Date
No Filing Data

Newron Pharmaceuticals SpA Analysis

Share your research